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Summary
The purpose of our study was to describe the clinical
characteristics of sporadic (S) cases of partial epilepsy
with auditory features (PEAF) and pinpoint clinical,
prognostic and genetic differences with respect to previ-
ously reported familial (F) cases of autosomal dominant
partial epilepsy with auditory features (ADPEAF). We
analysed 53 patients (24 females and 29 males) with
PEAF diagnosed according to the following criteria:
partial epilepsy with auditory symptoms, negative fam-
ily history for epilepsy and absence of cerebral lesions
on NMR study. All patients underwent a full clinical,
neuroradiological and neurophysiological examination.
Forty patients were screened for mutations in LGI1/epi-
tempin, which is involved in ADPEAF. Age at onset
ranged from 6 to 39 years (average 19 years).
Secondarily generalized seizures were the most common
type of seizures at onset (79%). Auditory auras
occurred either in isolation (53%) or associated with
visual, psychic or aphasic symptoms. Low seizure fre-
quency at onset and good drug responsiveness were
common, with 51% of patients seizure-free. Seizures
tended to recur after drug withdrawal. Clinically, no
major differences were found between S and F patients
with respect to age at onset, seizure frequency and
response to therapy. Analysis of LGI1/epitempin exons
failed to disclose mutations. Our data support the exist-
ence of a peculiar form of non-lesional temporal lobe
epilepsy closely related to ADPEAF but without a posi-
tive family history. This syndrome, here named IPEAF,
has a benign course in the majority of patients and
could be diagnosed by the presence of auditory aura.
Although LGI1 mutations have been excluded, genetic
factors may play an aetiopathogenetic role in at least
some of these S cases.
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Abbreviations: ADPEAF = autosomal dominant partial epilepsy with auditory features; AED = anti-epileptic drug; CI =
con®dence interval; DHPLC = denaturing high-performance liquid chromatography; F = familial; FS = febrile seizure;
LGI1 = leucine-rich, glioma-inactivated 1 gene; MTS = mesial temporal sclerosis; PEAF = partial epilepsy with auditory
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Introduction
Temporal lobe epilepsy (TLE) is the most common form of
partial epilepsy and is frequently associated with mesial
temporal sclerosis (MTS). Intensive research on refractory
cases, stimulated by interest in surgical treatment, has
documented common aetiologies and clinical characteristics
of lesional cases of TLE. Otherwise, little is known about the
aetiologies and outcome of non-lesional cases. From epi-
demiological reviews, it appears that non-lesional TLE is not
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a uniform disorder, but includes patients with severe refrac-
tory epilepsy and cases with a mild epileptic disorder who
enter remission with or without antiepileptic medication
(Hauser, 1992; Aguglia et al., 1998).
In recent years, growing evidence has indicated that a
genetic predisposition appears to be an important causal
factor of TLE and familial clustering of the disorder has been
reported (Ottman et al., 1995; Scheffer et al., 1995; Berkovic
et al., 1996; Cendes et al., 1998). According to seizure
semiology, familial TLE can be divided into two main
categories, one with mesial temporal lobe symptoms
(Berkovic et al., 1996) and one with lateral symptoms
(Ottman et al., 1995). Whereas familial mesial TLE is a
heterogeneous condition (Berkovic et al., 1996; Cendes et al.,
1998), familial lateral TLE appears to be more homogeneous,
characterized by simple partial seizures with mainly auditory
hallucinations (Winawer et al., 2002).
In 1995, Ottman described the ®rst pedigree in which most
of the affected members reported seizures with acoustic
symptoms usually followed by secondary generalization and
named the syndrome autosomal dominant partial epilepsy
with auditory features [ADPEAF (OMIM 600512)]. To date,
another 20 families have been reported (Poza et al., 1999;
Ikeda et al., 2000; Mautner et al., 2000; Michelucci et al.,
2000, 2003; Brodtkorb et al., 2002; Santos et al., 2002;
Wallace et al., 2002; Winawer et al., 2002; Fertig et al., 2003;
Pizzuti et al., 2003) with similar phenotype, clarifying the
main features of the syndrome that are characterized by
autosomal dominant transmission with high penetrance, onset
in the second and third decades of life, recurrent auditory aura
usually followed by generalized seizures, low seizure
frequency and benign outcome with good drug response.
Recently, mutations causing ADPEAF have been found in the
leucine-rich, glioma-inactivated 1 gene, LGI1, (Kalachikov
et al., 2002; Morante-Redolat et al., 2002). The gene is
located on chromosome 10q24 and was renamed `epitempin'
(Morante-Redolat et al., 2002). The function of this gene is
unknown, but a role in neuronal migration has been
postulated (Cowell et al., 2002; Gu et al., 2002). The
exclusion of linkage to 10q24 in one ADPEAF family and the
absence of LGI1 mutations in a few other families suggest
that this syndrome may be genetically heterogeneous (Bisulli
et al., 2002; Michelucci et al., 2003). Evidence that patients
with familial aphasic seizures have mutations in the same
gene, ®rst shown in a Norwegian family (Gu et al., 2002),
further widens the clinical spectrum of this condition. Thus,
the term autosomal dominant lateral temporal epilepsy
(ADLTE) rather than ADPEAF has been proposed (Poza
et al., 1999; Michelucci et al., 2003), focusing on seizure
onset from the lateral portion of the temporal lobe and
therefore including other symptoms (visual and aphasic)
which recurred in these families in isolation or associated
with auditory auras.
Although interest in auditory auras has recently been
aroused by the discovery of these ADPEAF cases, auditory
symptoms are well known in partial epilepsy of any aetiology
and have always been considered a characteristic of temporal
lobe seizures (Wunderlich et al., 2000). Auditory seizures
were ®rst reported by Holmes as early as 1927 (Holmes,
1927). Lennox reported a 2.4% incidence of auditory aura
among 1359 epileptic patients (Lennox, 1960). This percent-
age rose to 16% in Currie's series of 666 patients with
temporal lobe seizures (Currie et al., 1971). Moreover,
Pen®eld and Kristiansen found only three patients out of 222
surgical cases, suggesting the rarity of this condition in
refractory epilepsies (Pen®eld and Kristiansen, 1951).
Therefore, auditory aura is a rare epileptic symptom if we
consider only lesional TLE but perhaps more frequent in
cryptogenetic cases even if the exact incidence is not
reported.
The purpose of our study was to describe the clinical
characteristics of sporadic (S) cases with partial epilepsy with
auditory features (PEAF) and pinpoint clinical, prognostic
and genetic differences with respect to previously reported
familial (F) cases with autosomal dominant partial epilepsy
with auditory features (ADPEAF).
Methods
Present series
Diagnosis of PEAF was made according to a clinical history of at
least two lifetime seizures with auditory features: a single cluster of
seizures was considered as a single episode. Possible candidates with
PEAF were identi®ed both with (i) a prospective observation of
patients admitted for the ®rst time to epilepsy centres participating in
the study from January 1999 to March 2003, and (ii) retrospectively
from the databases of the centres and reviewing all clinical records.
All candidates of the latter group, with long-lasting disease followed
at our centres for many years, had a seizure diary and clinical
evaluation visits at least every 6 months. Moreover, they were
recalled and re-examined personally.
The study population therefore included both patients with newly
diagnosed epilepsy and some patients with long-standing disease.
Among these patients, we selected those responding to the following
inclusion criteria: (i) absence of ®rst- and second-degree relatives
(siblings, offspring, parents, grandparents, aunts and uncles) with
epileptic seizures; (ii) absence of clear-cut neuroradiological
abnormalities, including MTS. Exclusion criteria were an insuf®-
cient or doubtful family history and lack of neuroimaging data.
The data from each patient were tabulated with full details of
seizure type, auras, seizure frequency, response to therapy, anti-
epileptic drug (AED) used, ictal and interictal EEG recording, and
neuroradiological ®ndings. Other clinical items tabulated were sex,
dominant hand, personal antecedents, family history, age at seizure
onset, follow-up duration, delay between seizure onset and
diagnosis, delay between onset of partial seizures with auditory
symptoms and secondarily generalized tonic or tonic±clonic seizures
(SGTCs).
Three investigators (F.B., R.M., P.S.) undertook personal
interviews with the patient and at least one relative, usually the
mother, to establish the family history (for febrile seizures, epilepsy,
mental retardation and neurological diseases) and potential personal
antecedent events such as severe asphyxia, severe head injury,
viral encephalitis, bacterial meningitis or cerebral abscess, and
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complicated febrile seizures. Febrile seizures (FS) were diagnosed
when convulsions associated with fever occurred between the age of
3 months and 5 years (Consensus development conference on febrile
seizures, National Institutes of Health, 1981).
All patients underwent repeated EEG recordings during wakeful-
ness and, when possible, during diurnal sleep induced by sleep
deprivation (18 patients). Each patient underwent high-resolution
NMR or CT scanning of the brain. Twenty millilitres of blood for
DNA extraction were collected from 40 patients after written
informed consent had been given.
Literature review
Previously reported cases of ADPEAF were identi®ed searching
articles in the National Library of Medicine's MEDLINE database
(from 1966 to 2003), focusing on the terms `ADPEAF' OR `LGI1'
OR `familial temporal lobe epilepsy' OR `auditory aura', and
checking the reference lists of identi®ed articles to ®nd additional
references.
We did a retrospective analysis of 119 cases of ADPEAF
belonging to the 19 families described so far (Table 1). Clinical
details were only accepted when unambiguous. Case numbers
therefore differ slightly among the parameters assessed. Other
reported families, mentioned in abstract form or with scant clinical
and electrophysiological data, were not included in our analysis
(Picard et al., 2000; Santos et al., 2002; Wallace et al., 2002).
Moreover, we excluded cases in which the pattern of inheritance was
not autosomal dominant (Bisulli et al., 2002) and the Kanemoto
family, in which affected members reported only aphasic seizures
without any auditory auras (Kanemoto et al., 2000).
Statistical analysis
Clinical data about S and F cases (the latter by each single study)
were reported as relative frequency (dichotomous data) and mean
(continuous data), with the 95% con®dence interval (CI).
Comparison of some clinical data was made by means of the forest
plot graphic presentation (Lewis and Clarke, 2001). According to
this method, the results are shown as squares (S patients) and circles
(F studies) centred on the point estimate of the result of each study. A
vertical line runs through the point estimate to show its 95% CI.
Mutation analysis
Genomic DNA was extracted using standard methods and all LGI1
exons were PCR-ampli®ed. Some PCR primer sequences have
already been reported (Michelucci et al., 2003); the others will be
made available on request. PCR fragments speci®c for exons 1, 6, 7
and 8 were analysed by denaturing high-performance liquid
chromatography (DHPLC; Transgenomic) at the appropriate tem-
peratures. This method has a sensitivity >90%. PCR fragments for
exon 2, 3, 4 and 5 turned out to be unsuitable for DHPLC analysis
and were therefore analysed by direct sequencing with the BigDye
Terminator Cycle Sequencing kit (Perkin Elmer Applied
Biosystems).
Results
Clinical data
We collected data on 119 PEAF cases out of 8000 epileptic
patients admitted for the ®rst time to the centres. Among
them, 53 ful®lled the inclusion criteria; 18 were identi®ed
with the prospective observation and 35 from the databases
and by reviewing clinical ®les of the epilepsy centres. The
remaining 66 patients were excluded because of insuf®cient
clinical and neuroradiological data (10 patients), positive
family history for epilepsy (41 patients) and symptomatic
aetiology (15 patients).
Clinical and EEG ®ndings compared with previously
reported ADPEAF families are shown in Table 1.
A family history of FS in second- and third-degree relatives
was noted in two patients. Medical histories were unremark-
able with respect to structural or metabolic insults. FS were
reported in ®ve patients, but none of them experienced
prolonged or complicated episodes. Neurological examin-
ation was normal.
Type of seizure
At onset, SGTCs were the most common type of seizures
occurring in 42 patients (79%). Some of these patients were
referred to us with a diagnosis of idiopathic generalized
epilepsy (11%). On the basis of a detailed epileptological
interview, 36 of these 42 patients were also found to suffer
from clear-cut focal, elementary (22 patients) or complex (14
patients) seizures (according to the international classi®cation
of seizures: Commission on Classi®cation and Terminology
of the International League Against Epilepsy, 1989) other
than SGTCs, while six had only SGTCs. Eleven patients had
only focal seizures (elementary two, complex six, both
elementary and complex three). Seizures occurred only
during wakefulness in 60% of patients and also during
sleep in 40%.
Auditory auras
The focal seizures (either elementary, complex or secondarily
generalized) were characterized by prominent auditory
symptoms in all patients because of the inclusion criteria.
Auditory auras were isolated in 53% of patients and
associated with other symptoms in the remainder. Three
patients with auditory symptoms also reported visual features
during the same attacks or in isolation. Psychic symptoms
such as dreamy state sensation, deÂjaÁ vu, deÂjaÁ vecu and
negative thoughts (like a feeling of dying) followed the
auditory auras in three cases. Dif®culty in speaking or loss of
speech comprehension accompanied the auditory symptoms
in ®ve patients. Only one patient described olfactory auras
and the remaining patients experienced auras characterized
by several symptoms in different associations.
Most of the patients (58.4%) described simple hallucin-
ations characterized by unformed sounds, like hissing,
buzzing and acoustic vibration. Other patients (40%) reported
complex auditory hallucinations characterized by well-
formed and occasionally quite speci®c acoustic symptoms,
like music or well-de®ned human voices. Negative auditory
symptoms, described as loss of hearing (as if they had become
Partial epilepsy with auditory features 1345
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deaf) or blocked ears, were reported by 24.5% of patients and
in four of them they were the only ictal manifestation. Few
patients (11.3%) described a distorted perception of sound.
These different types of auditory symptoms could be isolated
or coexist in the same seizures.
Asking patients if they were able to lateralize the origin of
auditory auras, only 28.3% of patients reported the symptom
con®ned to one ear while most of them (56.6%) were not able
to localize the origin of aura exactly. In 15% of patients, aura
was bilateral. Five patients reported speci®c triggering
stimuli of seizures. Sudden noises (two patients), ¯owing
water (e.g. toilet ¯ushing; two patients) or answering the
phone (one patient) could precipitate the seizures, which also
occurred spontaneously.
Seizure frequency
Seizure frequency was generally low: before treatment
SGTCs were sporadic or occurred a maximum of three
times per year in 90.5% of patients (Fig. 1B), whereas
elementary or complex partial seizures were more frequent,
occurring more than once per month in 38.3%. When both
seizure types were present, partial seizures usually preceded
SGTCs by some years (mean 5.6 years). However, given the
mild intensity of the auditory auras, these could continue
unrecognized for several years, causing delayed diagnosis
(mean 4.4 years) because of no medical counselling (®ve
patients) or misdiagnosis (six patients).
Outcome after therapy
The outcome after therapy was good in the majority of
patients, with a reduction of seizures by more than 50% in 44
out of 51 patients who started therapy (86.2%) (Fig. 2A).
Twenty-seven patients (51%) have been seizure-free for at
least 1 year, with an average period of 8.3 years (Fig. 2C). In a
further 49% of cases, attacks became milder, usually
represented by the auditory auras, and less frequently with
sporadic seizures or a few seizures per year in 77% of patients
(Table 1). Only six patients still have SGTCs (mean follow-
up 2.8 6 3 years).
Monotherapy was usually effective, sometimes at low
doses, in the majority of patients (66%) (Fig. 2B); only 26%
of patients used two or more AED. Carbamazepine was the
most common AED used (55%). Two patients refused
antiepileptic medication as their ictal symptoms were mild.
Thirteen patients interrupted the treatment after a few years of
seizure-freedom: seizure recurrence was high (87%) and after
resumption of therapy four patients failed to regain control of
seizures, experiencing rare episodes of auditory auras
(Table 1).
Neuroimaging
A high-resolution NMR scan was available in 47 patients; the
other six individuals had a CT scan. All the investigations
were reviewed and were normal in all except six patients, who
had a slight, not signi®cant asymmetry of the temporal horns
(one patient), lateral ventricles (two patients) and hippocam-
pus without clear-cut evidence of MTS (three patients).
Sporadic versus familial
The distributions of sex, age at onset, the absence of relevant
antecedent events and other electroclinical features in our S
patients did not differ from those in the ADPEAF cases
(Table 1). A history of FS was reported in ®ve patients of the
S group, whereas within the literature cases only one member
of Ikeda's family experienced FS (Ikeda et al., 2000). SGTCs
at onset occurred in a high percentage of patients in both
groups but were more common in ADPEAF cases (Fig. 1A).
Moreover, the frequency of this type of seizures at onset was
similar in the two groups, with no more than a few attacks per
year in the majority of patients (Fig. 1B).
The focal seizures (either elementary, complex or second-
arily generalized) were characterized by prominent auditory
auras in all S cases because of the inclusion criteria, whereas
not all F cases had auditory symptoms (Table1).
Good drug response, with reduction of seizure frequency of
more than 50%, was common in both groups (Fig. 2A).
Usually monotherapy was suf®cient to control seizures in
most patients (Fig. 2B). The percentage of seizure-free
subjects was higher in the F cases, though the difference was
not statistically signi®cant as the 95% CIs overlapped
(Fig. 2C). The relapse rate after drug withdrawal, which
was high in both groups, was slightly higher in the S cases
(Table 1). Moreover, all familial cases became seizure-free
again after resuming therapy, whereas only 69% of the
sporadic cases regained control.
Genetic data
To test whether LGI1 mutations might occur in sporadic
PEAF cases, possibly as de novo mutations, we screened the
eight LGI1 exons by DHPLC or direct sequencing. No
mutations were found in our series of sporadic patients, nor
were other types of sequence alterations or polymorphic
variations detected in the coding region of the gene.
Discussion
Non-lesional TLE is not a uniform disorder since it encom-
passes both patients with a severe refractory form and cases
with a mild epileptic disorder achieving remission with or
without antiepileptic medication (Hauser, 1992; Aguglia
et al., 1998). As most studies on TLE have originated from
groups with a special interest in surgical treatment, informa-
tion to date has mostly concerned patients with refractory
TLE (French et al., 1993; Williamson et al., 1993; Jack et al.,
1994). Conversely, the mild form of non-lesional TLE
remains an unde®ned entity from an aetiological and
electroclinical point of view. In 1998, Aguglia et al.,
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comparing mild non lesional TLE with severe cases,
concluded that the mild form is characterized by a higher
prevalence of familial history of epilepsy and a much less
common association with MTS, suggesting a major aetio-
pathogenetic role of genetic factors (Aguglia et al., 1998).
Finally, they suggested that onset of seizures during adult-
hood indicates a good prognosis in non-lesional TLE, which
is con®rmed by our ®ndings. No other prognostic factor was
identi®ed to distinguish between a favourable or unfavour-
able outcome from the beginning.
The present study describes a homogeneous population of
patients with TLE selected on the basis of auditory auras and
absence of a familial trait and symptomatic aetiology. This
entity is probably underestimated and may often pass
undiagnosed: because of the mild nature of the seizures
many patients had a diagnosis delayed by months or years,
Fig. 1 Forest plot comparing the relative frequencies (95% CI) of patients with SGTCs at onset (A) and patients with SGTCs occurring
fewer than three times per year (B). The results are shown as squares (present series) and circles (F studies) centred on the point estimate
of the result of each study. A vertical line runs through the point estimate to show its con®dence interval. In calculating the relative
frequencies of patients with SGTCs (A), we excluded patients in whom focal ictal onset of tonic±clonic seizures could not be established
(see Table 1, UOTC). The results are shown as squares (present series) and circles (F studies) centred on the point estimate of the result of
each study. A vertical line runs through the point estimate to show its CI.
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often with the onset of the ®rst SGTCs. On the other hand, the
high incidence of SGTCs in our population, as in literature
reports, and their frequent occurrence during sleep without
any conscious auditory aura prompted the misdiagnosis of
idiopathic generalized epilepsy in 11% of our patients. For
these reasons, auditory symptoms must be speci®cally
Fig. 2 Forest plot comparing the relative frequencies of response to therapy >50% (A), monotherapy (B) and seizure-free patients (C) in
ADPEAF cases and in the present series.
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investigated by the clinician also in those patients presenting
with apparently generalized seizures.
Our data suggest that PEAF could represent a benign
clinical entity within the larger group of non-lesional TLE
and that auditory auras can represent a predictor of good
outcome. In all our cases, the diagnosis of ADPEAF was
®rmly excluded by interviewing more than one family
member and constructing the patient's family tree. In
addition, our de®nition of sporadic cases was more rigid
than Briellmann's criteria as we also excluded patients having
a second-degree relative with epilepsy (Briellmann et al.,
2001). However, in our S cases some clinical features, such as
the age at onset, seizure patterns and the favourable outcome,
are very similar to those of ADPEAF. We found only a few
possible, but not statistically signi®cant, differences between
the two groups: a higher incidence of FS in S cases, a more
common incidence of SGTCs at onset in familial cases
(meaning a more invalidating type of seizures), a higher
number of seizure-free patients and a slightly better response
to therapy in F cases compared with S cases. The latter two
differences may be explained, however, by a difference in the
diagnostic work-up between the two series. First, our patients
were instructed to carefully record the elementary auditory
auras in their seizure diaries, producing a lower number of
seizure-free patients. Secondly, we directly investigated all
our patients whereas literature cases sometimes were not seen
directly by the physician and information even included data
on deceased patients. Another reason could be that the mean
age at observation was lower in our group of patients.
Similarly, the EEG ®ndings provided more paroxysmal
abnormalities in S than in F patients, due to a more accurate
and detailed neurophysiological study in our cohort. If these
differences are disregarded as partly due to differences in the
evaluation of clinical items and in the diagnostic work-up,
there were no major clinical differences between the S and F
groups and both have a benign prognosis.
The similarities with ADPEAF, the benign outcome and
absence of lesions suggest that at least some of these cases
have a genetic aetiology. To date, 15 LGI1 mutations have
been reported in ADPEAF families, resulting in either protein
truncation or amino acid substitution (Gu et al., 2002;
Kalachikov et al., 2002; Morante Redolat et al., 2002;
Wallace et al., 2002; Fertig et al., 2003; Kobayashi et al.,
2003; Michelucci et al., 2003; Hedera et al., 2004). None of
these mutations were detected in our series. We also failed to
detect other types of nucleotide sequence alterations or
polymorphic variations in the coding LGI1 exons. Recently, a
GABA(B) receptor 1 polymorphism resulting in the amino
acid substitution Gly489Ser was found to be a strong risk
factor for non-lesional TLE in an Italian series of sporadic
TLE cases (Gambardella et al., 2003). Another association
study implicated a functional polymorphism of the prody-
norphin gene promoter in the aetiology of TLE (Stogmann
et al., 2002). In the light of these studies, it is conceivable that
genetic factors, particularly gene polymorphisms, contribute
to susceptibility to sporadic PEAF.
Finally, in the current ILAE classi®cation of epilepsy
syndromes (1989), the term `idiopathic' is reserved for
syndromes of presumed genetic origin, and the term
`cryptogenic' for conditions presumed to be non-genetic but
with insuf®cient evidence to assign a speci®c aetiology.
Because of the complexity in the genetic contribution to the
epilepsies, clinical syndromes cannot be divided into two
broad classes based on genetic susceptibility. For these
reasons, Ottman suggested addressing the question of genetic
susceptibility separately from the correct de®nition of
`idiopathic' rather than `cryptogenic' (Ottmann et al.,
1995). According to Engel, we believe it more appropriate
to use the term `idiopathic' only on a clinical basis, referring
to a syndrome with no underlying structural brain lesion or
other neurological sign or symptoms presumed to be genetic
(Engel, 2001). For this reason it could be meaningful to
consider the majority of our patients as idiopathic cases and
use the term `IPEAF' (idiopathic partial epilepsy with
auditory features).
We conclude that IPEAF is a benign, non-age-related
clinical entity within non-lesional TLE. Because of its
peculiar clinical picture, however, it may often pass
unrecognized or be misdiagnosed for a long time. Even if
LGI1 mutations have been excluded, genetic factors may play
an aetiopathogenetic role in at least some of these S cases. A
separate analysis of non-lesional TLE with auditory symp-
toms is useful and S cases should be included in molecular
genetic studies, as proposed by Briellmann and colleagues for
generalized epilepsy (Briellmann et al., 2001).
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